Last reviewed · How we verify
Mycophenolate mofetil,methotrexate — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Mycophenolate mofetil,methotrexate (Mycophenolate mofetil,methotrexate) — Assistance Publique - Hôpitaux de Paris.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Mycophenolate mofetil,methotrexate TARGET | Mycophenolate mofetil,methotrexate | Assistance Publique - Hôpitaux de Paris | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Mycophenolate mofetil,methotrexate CI watch — RSS
- Mycophenolate mofetil,methotrexate CI watch — Atom
- Mycophenolate mofetil,methotrexate CI watch — JSON
- Mycophenolate mofetil,methotrexate alone — RSS
Cite this brief
Drug Landscape (2026). Mycophenolate mofetil,methotrexate — Competitive Intelligence Brief. https://druglandscape.com/ci/mycophenolate-mofetil-methotrexate. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing